These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 31876105

  • 1. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
    Huang Y, Wang Y, Chang Y, Yuan X, Hao L, Shi H, Lai Y, Huang X, Liu Y.
    Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms.
    El Hussein S, Wang W.
    Cancers (Basel); 2024 Jun 01; 16(11):. PubMed ID: 38893237
    [Abstract] [Full Text] [Related]

  • 5. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
    Zalmaï L, Viailly PJ, Biichle S, Cheok M, Soret L, Angelot-Delettre F, Petrella T, Collonge-Rame MA, Seilles E, Geffroy S, Deconinck E, Daguindau E, Bouyer S, Dindinaud E, Baunin V, Le Garff-Tavernier M, Roos-Weil D, Wagner-Ballon O, Salaun V, Feuillard J, Brun S, Drenou B, Mayeur-Rousse C, Okamba P, Dorvaux V, Tichionni M, Rose J, Rubio MT, Jacob MC, Raggueneau V, Preudhomme C, Saas P, Ferrand C, Adotevi O, Roumier C, Jardin F, Garnache-Ottou F, Renosi F.
    Haematologica; 2021 Dec 01; 106(12):3056-3066. PubMed ID: 33054115
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?
    Osaki Y, Yokohama A, Saito A, Tahara K, Yanagisawa K, Ogawa Y, Ishizaki T, Mitsui T, Koiso H, Takizawa M, Uchiumi H, Saitoh T, Handa H, Murakami H, Tsukamoto N, Nojima Y.
    PLoS One; 2013 Dec 01; 8(11):e81722. PubMed ID: 24312342
    [Abstract] [Full Text] [Related]

  • 8. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
    Yu H, Zhang P, Yin X, Yin Z, Shi Q, Cui Y, Liu G, Wang S, Piccaluga PP, Jiang T, Zhang L.
    Protein Cell; 2015 Apr 01; 6(4):297-306. PubMed ID: 25779340
    [Abstract] [Full Text] [Related]

  • 9. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.
    Roussel X, Garnache Ottou F, Renosi F.
    Cancers (Basel); 2022 Jul 21; 14(14):. PubMed ID: 35884612
    [Abstract] [Full Text] [Related]

  • 10. Plasmacytoid dendritic cell neoplasms.
    Lee YJ, Kim Y, Park SH, Jo JC.
    Blood Res; 2023 Apr 30; 58(S1):90-95. PubMed ID: 37105563
    [Abstract] [Full Text] [Related]

  • 11. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
    Peng J, He S, Yang X, Huang L, Wei J.
    Crit Rev Oncol Hematol; 2023 Dec 30; 192():104186. PubMed ID: 37863402
    [Abstract] [Full Text] [Related]

  • 12. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
    Xiao W, Chan A, Waarts MR, Mishra T, Liu Y, Cai SF, Yao J, Gao Q, Bowman RL, Koche RP, Csete IS, DelGaudio NL, Derkach A, Baik J, Yanis S, Famulare CA, Patel M, Arcila ME, Stahl M, Rampal RK, Tallman MS, Zhang Y, Dogan A, Goldberg AD, Roshal M, Levine RL.
    Blood; 2021 Mar 11; 137(10):1377-1391. PubMed ID: 32871587
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W, Khoury JD, Miranda RN, Jorgensen JL, Xu J, Loghavi S, Li S, Pemmaraju N, Nguyen T, Medeiros LJ, Wang SA.
    Haematologica; 2021 Apr 01; 106(4):1047-1055. PubMed ID: 32241840
    [Abstract] [Full Text] [Related]

  • 17. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
    Song J, Li W, Bai Y, Zhou P, Niu J, Niu X, Liu Y, Liu X, Drokow EK, Sun K, Zhou H.
    Ann Hematol; 2024 Feb 01; 103(2):463-473. PubMed ID: 38183444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Beird HC, Khan M, Wang F, Alfayez M, Cai T, Zhao L, Khoury J, Futreal PA, Konopleva M, Pemmaraju N.
    Blood Cancer J; 2019 Dec 06; 9(12):99. PubMed ID: 31811114
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch JH, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U.
    Ann Hematol; 2024 May 06; 103(5):1587-1599. PubMed ID: 38194088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.